Amarantus Bioscience Holdings Inc (AMBS)

[newflow]

In Supreme court Sequenom, Inc. v. Ariosa Diagnostics, Inc.
http://www.scotusblog.com/case-files/cases/sequenom-inc-v-ariosa-diagnostics-inc/


"STATEMENT OF INTEREST OF AMICI CURIAE1
Amicus Curiae Amarantus Bioscience Holdings,
Inc. (“Amarantus”) is a small entrepreneurial biotechnology
company focused on commercializing new
diagnostics and therapeutics. Through its diagnostics
division, Amarantus is developing the LymPro Test®,
which is a blood-based assay to diagnose Alzheimer’s
disease, and MSPrecise®, which is a proprietary,
next-generation DNA-sequencing assay for identification
of patients with relapsing-remitting multiple
sclerosis.
Amarantus is also developing: a drug (Eltoprazine)
to treat quality-of-life degrading symptoms
associated with Parkinson’s disease; an engineered
skin to replace skin lost by burn victims who are
burned on at least fifty percent of the surface area of
their bodies; and a peptide therapeutic, MANF,
currently indicated for the treatment of Retinitis
Pigmentosa."